We are live on ! Find out more
CGTX icon

Cognition Therapeutics
CGTX

32 hedge funds and large institutions have $13.8M invested in Cognition Therapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more capital invested

Capital invested by funds: $10.1M → $13.8M (+$3.72M)

6% less funds holding

Funds holding: 34 → 32 (-2)

7.41% less ownership

Funds ownership: 31.81% → 24.4% (-7.4%)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$188K
2
FC
FCA Corp
Texas
+$98.1K
3
KAS
Kestra Advisory Services
Texas
+$84.6K
4
HighTower Advisors
HighTower Advisors
Illinois
+$54.4K
5
Neuberger Berman Group
Neuberger Berman Group
New York
+$30.3K

Top Sellers

Rank Fund Capital Flow
1
PFO
Pathstone Family Office
New Jersey
-$4.21M
2
Wells Fargo
Wells Fargo
California
-$73.1K
3
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$39.3K
4
Two Sigma Investments
Two Sigma Investments
New York
-$35K
5
WAAG
Wealth Alliance Advisory Group
Kansas
-$29.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
PFO
1
Pathstone Family Office
New Jersey
$4.38M -$4.21M -2,210,377 -50%
ACM
2
AIGH Capital Management
Maryland
$4.03M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.27M +$188K +98,501 +18%
WVP
4
Worth Venture Partners
New Jersey
$993K – – –
CC
5
Carlson Capital
Texas
$485K +$29.1K +15,269 +7%
PWM
6
Perigon Wealth Management
California
$446K -$1.91K -1,000 -0.4%
AFG
7
American Financial Group
Ohio
$406K – – –
VC
8
Voss Capital
Texas
$317K -$13.2K -6,930 -4%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$243K – – –
KAS
10
Kestra Advisory Services
Texas
$188K +$84.6K +44,382 +88%
BCM
11
Bridgeway Capital Management
Texas
$131K – – –
FC
12
FCA Corp
Texas
$102K +$98.1K +51,471 New
RCG
13
Rock Creek Group
District of Columbia
$99K – – –
CWM
14
Castle Wealth Management
Florida
$85.9K – – –
BlackRock
15
BlackRock
New York
$74.7K +$2.14K +1,122 +3%
NCM
16
Neumann Capital Management
California
$66.1K – – –
State Street
17
State Street
Massachusetts
$59.9K – – –
HighTower Advisors
18
HighTower Advisors
Illinois
$58K +$54.4K +28,561 New
Northern Trust
19
Northern Trust
Illinois
$57.8K – – –
Two Sigma Investments
20
Two Sigma Investments
New York
$55.9K -$35K -18,384 -39%
NFC
21
Northeast Financial Consultants
Connecticut
$48.5K – – –
Baird Financial Group
22
Baird Financial Group
Wisconsin
$44.3K +$4.38K +2,300 +11%
Morgan Stanley
23
Morgan Stanley
New York
$43.3K – – –
BSB
24
Bangor Savings Bank
Maine
$37.7K – – –
Neuberger Berman Group
25
Neuberger Berman Group
New York
$31.4K +$30.3K +15,884 New
1
2

CGTX Hedge Fund Activity: Q1 2023 in Review

32 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q1 2023, worth a combined $13.8M — up 37% from $10.1M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CGTX and 4 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $188K. The largest seller was Pathstone Family Office, cutting an estimated $4.21M.

  • 32 institutional investors held Cognition Therapeutics (CGTX) as of Q1 2023, down from 34 in Q4 2022.
  • Funds reported $13.8M of Cognition Therapeutics stock for Q1 2023, up 37% quarter-over-quarter.
  • 4 funds opened new Cognition Therapeutics positions in Q1 2023 and 5 closed out, a net change of -1 holder.
  • The largest Cognition Therapeutics buyer in Q1 2023 was Vanguard Group, an estimated $188K added.
  • The largest Cognition Therapeutics seller in Q1 2023 was Pathstone Family Office, an estimated $4.21M sold.

Based on aggregated 13F filings for Q1 2023.